NCT06673498: Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery
- State
- Under way
- Phase
- Phase 2
- People
- 60 planned
- Started
- 10 Nov 2024
- Primary completion
- 30 Nov 2025
- Arms
- Treatment group
- Results
- None posted
- 5 Nov 2024: Trial registered